The call for proposals is just days away! Mucinous Ovarian Cancer Coalition/MOCC invites researchers to submit abstracts for requests of up to $50,000. Find the full guidelines here: https://t.co/9CQUvByhpp @Frumovitz @katiekurnit @JennyMueller_ @SGO_org

We now have FOUR potential clinical trials open at @MDAndersonNews for patients with small cell/large cell/neuroendocrine cervical cancer. Both targeted and immunotherapies. Excited to offer so many opportunities to patients with this rare cancer @SARCC @LaurenByersMD

Clinicopathologic characteristics, oncologic outcomes & prognostic factors in #neuroendocrine #CervicalCarcinoma #NECTURstudy @ajhingran @MDAndersonNews @frumovitz https://t.co/cet8ATJXMJ @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert

Honored to receive the Felix Rutledge Society travel award and excited to be presenting my research at this year’s annual @WAGO_org meeting! I am so grateful for my Hopkins family and amazing mentors 😊 @HopkinsGynOnc @MDAndersonNews

“This is likely the most comprehensive book for these rare gynecological cancers.” -©Doody’s Review Service, 2023. Read full review: https://t.co/3B1ptlSort @frumovitz, @leitaomd, @NancyDEditor

The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce "Rhonda's Award 2023" is now open. We will accept submissions for grants up to $50,000. Focus must be on #MucinousOvarianCancer Find more details here: https://t.co/9CQUvByhpp

“Both the physical textbook and the ebook achieve this goal and provide guidance from workup to primary treatment to recurrence and surveillance strategies.” -©Doody’s Review Service, 2023. Read full review: https://t.co/3McKV1UJY5 @frumovitz @leitaomd @NancyDEditor

Diagnosis and Treatment of Rare Gynecologic Cancers https://t.co/cjkBmQ5ttL #Amazon

Patient Experience rounds are back @MDAndersonNews with @Frumovitz CPXO. Outstanding work going on in Head and Neck Center improving responsiveness and informing about wait times. Their scores reflect their hard work! All domains reached goal this quarter! #ServiceExcellence

So excited to be at the @Allyson4Rare gala in support of young people with cancer. So appreciative of their amazing support of our #NECC research. @MDAndersonNews @SCCCLCCCSisters

The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce Dr. Kylie Gorringe as the recipient of Rhonda's Award. Find all of the details about this annual grant and Dr. Gorringe here: https://t.co/Lq0WMZ7VIE @Frumovitz @JennyMueller_ @katiekurnit

The deadline to apply for up to $50,000 to fund research on mucinous ovarian cancer is July 14th. Find details about Rhonda's Award here: https://t.co/9CQUvByhpp @Frumovitz @JennyMueller_ @katiekurnit

$50K Rhonda’s Award to support research in mucinous ovarian cancer now being offered by the Mucinous Ovarian Cancer Coalition/MOCC. Details/deadlines here: https://t.co/8MN4NHQ7De Great opportunity for research in this #raretumor @SGO_org @ESGO_society @IGCSociety @ShelleyMLM

Excited to share a new research award for mucinous ovarian cancer! Application now open, deadline on 6/2. Can’t wait to make some much needed progress for this #raretumor @ShelleyMLM @Frumovitz @JennyMueller_

We are the Mucinous Ovarian Cancer Coalition. Launched by my late sister in September of 2020. In addition to financial supportnd opinions, and resources, we fund research grants. RFPs for Rhonda’s Award begins on June 2nd for grants up to $50k. https://t.co/tFgEAIE4kv #gyncsm

Our trial with immunotherapy AK104 (cadonilimab) for women with neuroendocrine cervix cancer at @MDAndersonNews opened just this week! We already have 1 enrolled and 2 in screening. Trials for #raretumors are possible! @SGO_org @NANETS1 @SCCCLCCCSisters @ShannonWestin @karenluMD

Stay tuned! Our trial with AK104 (cadonilimab), a bispecific PD1/CTLA4 antibody, for women with neuroendocrine cervical cancer should open next week! So close!! @SCCCLCCCSisters @SGO_org @NANETS1

Health care providers, join us tonight’s Physician Advisory Council meeting, where we will be joined by MD Anderson President Dr. Peter WT Pisters. The virtual event is from 6-7 p.m. CST. Register here: https://t.co/ZWGSnANhJC @PPisters #EndCancer

Excited to announce our clinical trial with surgery and #HIPEC for recurrent mucinous ovarian cancer is now open at @MDAndersonNews. Will also open at MSKCC later this year with our colleagues @zivanovicmd and @JennyMueller_. @ShelleyMLM @katiekurnit @AnilSoodMD

Our lab at @MDAndersonNews draws blood from > 15,000 patients/week and always provides outstanding #serviceexcellence to every single one of our cancer patients. Congratulations for their outstanding patient scores for #patientexperience. @BethGarciaMDA